HuZAF

HuZAF Uses, Dosage, Side Effects, Food Interaction and all others data.

HuZAF (marketed under the trade name HuZAF™) is a humanized monoclonal antibody which is used as an immunosuppressive drug to treat Crohn's disease.

Table Of contents

• HuZAF
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	HuZAF
Generic	Fontolizumab
Fontolizumab Other Names	Fontolizumab
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in crohn's disease and psoriasis and psoriatic disorders.

How HuZAF works

HuZAF is a humanised antibody directed against recombinant human IFN-{gamma}. The antibody binds to natural human IFN-{gamma} and inhibits expression of IFN-{gamma} regulated genes known to be upregulated in Crohn’s disease.

Innovators Monograph

You find simplified version here HuZAF